MetaADEDB 2.0 @ LMMD
PCI 32765
(XYFPWWZEPKGCCK-GOSISDBHSA-N)
Structure
SMILES
C=CC(=O)N1CCC[C@H](C1)n1nc(c2c1ncnc2N)c1ccc(cc1)Oc1ccccc1
Type(s)
Approved
ATC code(s)
L01XE27
Molecular Formula:
C25H24N6O2
Molecular Weight:
440.497
Log P:
4.7364
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
99.16
CAS Number(s):
936563-96-1
Synonym(s)
1.
PCI 32765
2.
PCI-32765
3.
PCI32765
4.
ibrutinib
External Link(s)
MeSHC551803
PubChem Compound24821094
BindingDB50357312
ChEBI76612
CHEMBLCHEMBL1873475
DrugBankDB09053
DrugCentral4810
IUPHAR/BPS Guide to PHARMACOLOGY6912
KEGGdr:D10223
Therapeutic Target DatabaseD09KTS
ZINC35328014
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Incorrect dose administeredFAERS: 832
Canada Vigilance: 49
Canada Vigilance
US FAERS
2FatigueFAERS: 707
Canada Vigilance: 200
Canada Vigilance
SIDER
US FAERS
3Atrial FibrillationFAERS: 606
Canada Vigilance: 89
Canada Vigilance
SIDER
US FAERS
4PneumoniaFAERS: 494
Canada Vigilance: 197
Canada Vigilance
SIDER
US FAERS
5Disease ProgressionFAERS: 361
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
6ArthralgiaFAERS: 330
Canada Vigilance: 65
Canada Vigilance
SIDER
US FAERS
7AstheniaFAERS: 325
Canada Vigilance: 87
Canada Vigilance
SIDER
US FAERS
8NauseaFAERS: 286
Canada Vigilance: 55
Canada Vigilance
SIDER
US FAERS
9DizzinessFAERS: 250
Canada Vigilance: 63
Canada Vigilance
SIDER
US FAERS
10Product use issueFAERS: 249
Canada Vigilance: 27
Canada Vigilance
US FAERS
11HeadacheFAERS: 211
Canada Vigilance: 30
Canada Vigilance
SIDER
US FAERS
12Peripheral swellingFAERS: 207
Canada Vigilance: 55
Canada Vigilance
US FAERS
13InfectionFAERS: 194
Canada Vigilance: 42
Canada Vigilance
SIDER
US FAERS
14MalaiseFAERS: 192
Canada Vigilance: 22
Canada Vigilance
US FAERS
15EpistaxisFAERS: 182
Canada Vigilance: 53
Canada Vigilance
SIDER
US FAERS
16Cerebrovascular accidentFAERS: 170
Canada Vigilance: 6
Canada Vigilance
US FAERS
17Weight decreasedFAERS: 170
Canada Vigilance: 39
Canada Vigilance
US FAERS
18Product use in unapproved indicationFAERS: 165
Canada Vigilance: 20
Canada Vigilance
US FAERS
19StomatitisFAERS: 165
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
20White blood cell count decreasedFAERS: 162
Canada Vigilance: 42
Canada Vigilance
US FAERS
21Urinary tract infectionFAERS: 158
Canada Vigilance: 41
Canada Vigilance
SIDER
US FAERS
22MyalgiaFAERS: 157
Canada Vigilance: 36
Canada Vigilance
US FAERS
23NeutropeniaFAERS: 154
Canada Vigilance: 42
Canada Vigilance
SIDER
US FAERS
24PainFAERS: 154
Canada Vigilance: 34
Canada Vigilance
US FAERS
25SepsisFAERS: 153
Canada Vigilance: 29
Canada Vigilance
US FAERS
26ThrombocytopeniaFAERS: 152
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
27VomitingFAERS: 150
Canada Vigilance: 29
Canada Vigilance
SIDER
US FAERS
28Adverse eventFAERS: 133
Canada Vigilance: 2
Canada Vigilance
US FAERS
29ConstipationFAERS: 133
Canada Vigilance: 35
Canada Vigilance
SIDER
US FAERS
30Drug dose omissionFAERS: 132US FAERS
31Drug ineffectiveFAERS: 130
Canada Vigilance: 24
Canada Vigilance
US FAERS
32NasopharyngitisFAERS: 116
Canada Vigilance: 49
Canada Vigilance
US FAERS
33PetechiaeFAERS: 114
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
34DehydrationFAERS: 109
Canada Vigilance: 15
Canada Vigilance
SIDER
US FAERS
35LymphadenopathyFAERS: 109
Canada Vigilance: 9
Canada Vigilance
US FAERS
36Blood count abnormalFAERS: 104
Canada Vigilance: 12
Canada Vigilance
US FAERS
37Back PainFAERS: 102
Canada Vigilance: 35
Canada Vigilance
US FAERS
38HypotensionFAERS: 101
Canada Vigilance: 9
Canada Vigilance
US FAERS
39Myocardial InfarctionFAERS: 91
Canada Vigilance: 10
Canada Vigilance
US FAERS
40PruritusFAERS: 91
Canada Vigilance: 9
Canada Vigilance
US FAERS
41Joint swellingFAERS: 84
Canada Vigilance: 20
Canada Vigilance
US FAERS
42Increased tendency to bruiseFAERS: 78
Canada Vigilance: 32
Canada Vigilance
US FAERS
43Chest PainFAERS: 77
Canada Vigilance: 12
Canada Vigilance
US FAERS
44AlopeciaFAERS: 76
Canada Vigilance: 8
Canada Vigilance
US FAERS
45InfluenzaFAERS: 74
Canada Vigilance: 19
Canada Vigilance
US FAERS
46PneumonitisFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
47SinusitisFAERS: 73
Canada Vigilance: 15
Canada Vigilance
SIDER
US FAERS
48Skin lesionFAERS: 73
Canada Vigilance: 9
Canada Vigilance
US FAERS
49Feeling abnormalFAERS: 72
Canada Vigilance: 6
Canada Vigilance
US FAERS
50DyspepsiaFAERS: 70
Canada Vigilance: 22
Canada Vigilance
SIDER
US FAERS
51OnychoclasisFAERS: 70
Canada Vigilance: 8
Canada Vigilance
US FAERS
52Abdominal discomfortFAERS: 66
Canada Vigilance: 12
Canada Vigilance
US FAERS
53Abdominal PainFAERS: 64
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
54Inappropriate schedule of drug administrationFAERS: 64US FAERS
55ChillsFAERS: 63
Canada Vigilance: 17
Canada Vigilance
SIDER
US FAERS
56BronchitisFAERS: 61
Canada Vigilance: 11
Canada Vigilance
US FAERS
57SyncopeFAERS: 61
Canada Vigilance: 6
Canada Vigilance
US FAERS
58Bone painFAERS: 60
Canada Vigilance: 3
Canada Vigilance
US FAERS
59LymphocytosisFAERS: 60
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
60Pericardial effusionFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
61Product dose omissionFAERS: 59
Canada Vigilance: 44
Canada Vigilance
US FAERS
62Dry skinFAERS: 57
Canada Vigilance: 9
Canada Vigilance
US FAERS
63CellulitisFAERS: 56
Canada Vigilance: 22
Canada Vigilance
US FAERS
64Memory impairmentFAERS: 55
Canada Vigilance: 11
Canada Vigilance
US FAERS
65Respiratory FailureFAERS: 53US FAERS
66SomnolenceFAERS: 51
Canada Vigilance: 6
Canada Vigilance
US FAERS
67White blood cell count abnormalFAERS: 51
Canada Vigilance: 2
Canada Vigilance
US FAERS
68Blood urine presentFAERS: 50
Canada Vigilance: 15
Canada Vigilance
US FAERS
69Cardiac ArrestFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Febrile NeutropeniaFAERS: 50US FAERS
71ThrombosisFAERS: 48
Canada Vigilance: 2
Canada Vigilance
US FAERS
72CystitisFAERS: 45
Canada Vigilance: 23
Canada Vigilance
US FAERS
73ErythemaFAERS: 45
Canada Vigilance: 8
Canada Vigilance
US FAERS
74General physical health deteriorationFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
75Lymphocyte count increasedFAERS: 45
Canada Vigilance: 3
Canada Vigilance
US FAERS
76Night sweatsFAERS: 45
Canada Vigilance: 14
Canada Vigilance
US FAERS
77Acute kidney injuryFAERS: 44
Canada Vigilance: 3
Canada Vigilance
US FAERS
78Productive CoughFAERS: 44
Canada Vigilance: 17
Canada Vigilance
US FAERS
79HypersensitivityFAERS: 43
Canada Vigilance: 3
Canada Vigilance
US FAERS
80PalpitationsFAERS: 43
Canada Vigilance: 10
Canada Vigilance
US FAERS
81PancytopeniaFAERS: 43
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
82Neutrophil count decreasedFAERS: 42
Canada Vigilance: 21
Canada Vigilance
US FAERS
83Oropharyngeal painFAERS: 42
Canada Vigilance: 17
Canada Vigilance
SIDER
US FAERS
84LeukocytosisFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Musculoskeletal PainFAERS: 40
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
86CataractFAERS: 39
Canada Vigilance: 12
Canada Vigilance
US FAERS
87Septic ShockFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
88Basal cell carcinomaFAERS: 38
Canada Vigilance: 9
Canada Vigilance
US FAERS
89ArthritisFAERS: 36
Canada Vigilance: 6
Canada Vigilance
US FAERS
90Depressed moodFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
91Skin UlcerFAERS: 36
Canada Vigilance: 7
Canada Vigilance
US FAERS
92Rash erythematousFAERS: 35
Canada Vigilance: 17
Canada Vigilance
US FAERS
93UrticariaFAERS: 35
Canada Vigilance: 2
Canada Vigilance
US FAERS
94Blood creatinine increasedFAERS: 33
Canada Vigilance: 4
Canada Vigilance
US FAERS
95EcchymosisFAERS: 33US FAERS
96Wrong technique in product usage processFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
97Musculoskeletal stiffnessFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
98GoutFAERS: 31
Canada Vigilance: 9
Canada Vigilance
US FAERS
99SplenomegalyFAERS: 31
Canada Vigilance: 14
Canada Vigilance
US FAERS
100Blood glucose increasedFAERS: 30
Canada Vigilance: 4
Canada Vigilance
US FAERS
101FlatulenceFAERS: 30
Canada Vigilance: 7
Canada Vigilance
US FAERS
102InflammationFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
103AmnesiaFAERS: 29
Canada Vigilance: 4
Canada Vigilance
US FAERS
104Clostridium difficile infectionFAERS: 29
Canada Vigilance: 12
Canada Vigilance
US FAERS
105HerniaFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
106Lower respiratory tract infectionFAERS: 29
Canada Vigilance: 29
Canada Vigilance
US FAERS
107Platelet count abnormalFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
108SwellingFAERS: 29
Canada Vigilance: 11
Canada Vigilance
US FAERS
109Urinary RetentionFAERS: 29
Canada Vigilance: 5
Canada Vigilance
US FAERS
110AcneFAERS: 28
Canada Vigilance: 13
Canada Vigilance
US FAERS
111DeafnessFAERS: 28US FAERS
112MYELODYSPLASTIC SYNDROMEFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
113NephrolithiasisFAERS: 28
Canada Vigilance: 6
Canada Vigilance
US FAERS
114TremorFAERS: 28
Canada Vigilance: 6
Canada Vigilance
US FAERS
115Blood blisterFAERS: 27
Canada Vigilance: 11
Canada Vigilance
US FAERS
116ColitisFAERS: 27US FAERS
117DysphoniaFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
118DysuriaFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
119Inappropriate schedule of product administrationFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
120AnxietyFAERS: 26
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
121CytopeniaFAERS: 26
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
122Mantle cell lymphomaFAERS: 26
Canada Vigilance: 11
Canada Vigilance
US FAERS
123Sudden deathFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
124Neck PainFAERS: 25
Canada Vigilance: 8
Canada Vigilance
US FAERS
125Richter's syndromeFAERS: 25
Canada Vigilance: 7
Canada Vigilance
US FAERS
126Visual ImpairmentFAERS: 25
Canada Vigilance: 6
Canada Vigilance
US FAERS
127Blood potassium decreasedFAERS: 24
Canada Vigilance: 4
Canada Vigilance
US FAERS
128Deep Vein ThrombosisFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
129Toxicity to various agentsFAERS: 24US FAERS
130Arthropod biteFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
131Atrial FlutterFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
132BradycardiaFAERS: 23
Canada Vigilance: 4
Canada Vigilance
US FAERS
133Feeling ColdFAERS: 23
Canada Vigilance: 10
Canada Vigilance
US FAERS
134Pulmonary EmbolismFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
135VertigoFAERS: 23
Canada Vigilance: 5
Canada Vigilance
US FAERS
136DysgeusiaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
137TachycardiaFAERS: 22US FAERS
138BlindnessFAERS: 21US FAERS
139Blood iron decreasedFAERS: 21
Canada Vigilance: 5
Canada Vigilance
US FAERS
140Blood sodium decreasedFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Chest discomfortFAERS: 21
Canada Vigilance: 4
Canada Vigilance
US FAERS
142Extra dose administeredFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
143Oral painFAERS: 21
Canada Vigilance: 5
Canada Vigilance
US FAERS
144Squamous cell carcinomaFAERS: 21
Canada Vigilance: 6
Canada Vigilance
US FAERS
145LacerationFAERS: 20SIDER
US FAERS
146UveitisFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
147ArthropathyFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
148DementiaFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
149LethargyFAERS: 19
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
150NoduleFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
151PericarditisFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
152Blood glucose decreasedFAERS: 18
Canada Vigilance: 6
Canada Vigilance
US FAERS
153Lymphocyte count decreasedFAERS: 18
Canada Vigilance: 5
Canada Vigilance
US FAERS
154LymphomaFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
155Mental status changesFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Product use complaintFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
157AsthmaFAERS: 17US FAERS
158Blood potassium increasedFAERS: 17US FAERS
159Burning sensationFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
160HypoxiaFAERS: 17US FAERS
161Immune thrombocytopenic purpuraFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
162PancreatitisFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
163PanniculitisFAERS: 17US FAERS
164Poor quality sleepFAERS: 17
Canada Vigilance: 12
Canada Vigilance
US FAERS
165PurpuraFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Therapeutic response unexpectedFAERS: 17
Canada Vigilance: 5
Canada Vigilance
US FAERS
167AscitesFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
168Ejection Fraction DecreasedFAERS: 16US FAERS
169OverdoseFAERS: 16US FAERS
170Ventricular FibrillationFAERS: 16US FAERS
171Acute respiratory failureFAERS: 15US FAERS
172ChromaturiaFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
173DiverticulitisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
174HypophagiaFAERS: 15US FAERS
175Ventricular arrhythmiaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
176Angina PectorisFAERS: 14US FAERS
177Bronchopulmonary AspergillosisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Prescribed underdoseFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Pulmonary FibrosisFAERS: 14US FAERS
180Transaminases increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Alanine Aminotransferase IncreasedFAERS: 13US FAERS
182Bacterial sepsisFAERS: 13US FAERS
183Diabetes MellitusFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
184Intestinal ObstructionFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
185Joint injuryFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
186LeukopeniaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
187OsteomyelitisFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
188Splenic RuptureFAERS: 13
Canada Vigilance: 4
Canada Vigilance
US FAERS
189Accidental overdoseFAERS: 12US FAERS
190Acute myocardial infarctionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Aspartate Aminotransferase IncreasedFAERS: 12US FAERS
192Blood immunoglobulin G decreasedFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
193Blood immunoglobulin M increasedFAERS: 12US FAERS
194Clostridium difficile colitisFAERS: 12
Canada Vigilance: 4
Canada Vigilance
US FAERS
195DeliriumFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
196Drug resistanceFAERS: 12US FAERS
197EpilepsyFAERS: 12US FAERS
198Gait inabilityFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
199GastritisFAERS: 12US FAERS
200PneumothoraxFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
201Squamous cell carcinoma of skinFAERS: 12US FAERS
202Supraventricular tachycardiaFAERS: 12US FAERS
203Tooth ExtractionFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
204AphasiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
205FlushingFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
206Limb discomfortFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
207OsteoporosisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
208PleurisyFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
209Pulmonary thrombosisFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
210Stevens-Johnson SyndromeFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Throat irritationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
212UlcerFAERS: 11US FAERS
213Urinary tract obstructionFAERS: 11US FAERS
214WheezingFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
215Blood immunoglobulin M decreasedFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
216CholelithiasisFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
217ConjunctivitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
218DiscomfortFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
219DisorientationFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
220Eye irritationFAERS: 10US FAERS
221Failure to ThriveFAERS: 10US FAERS
222HypersomniaFAERS: 10
Canada Vigilance: 7
Canada Vigilance
US FAERS
223PolyneuropathyFAERS: 10US FAERS
224PsoriasisFAERS: 10US FAERS
225ScabFAERS: 10US FAERS
226Skin lacerationFAERS: 10
Canada Vigilance: 4
Canada Vigilance
US FAERS
227Skin reactionFAERS: 10US FAERS
228Splenic InfarctionFAERS: 10US FAERS
229StressFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Unevaluable eventFAERS: 10US FAERS
231Urinary IncontinenceFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
232BiopsyFAERS: 9
Canada Vigilance: 6
Canada Vigilance
US FAERS
233Blood alkaline phosphatase increasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
234Cardiac TamponadeFAERS: 9US FAERS
235CardiomegalyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Facial paralysisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
237HaematotoxicityFAERS: 9US FAERS
238ImmunosuppressionFAERS: 9US FAERS
239Malignant neoplasm progressionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
240Muscle strainFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
241NeuralgiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
242Product difficult to swallowFAERS: 9US FAERS
243Pyoderma GangrenosumFAERS: 9US FAERS
244SciaticaFAERS: 9
Canada Vigilance: 4
Canada Vigilance
US FAERS
245TinnitusFAERS: 9US FAERS
246furuncleFAERS: 9
Canada Vigilance: 4
Canada Vigilance
US FAERS
247jaundiceFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
248AppendicitisFAERS: 8US FAERS
249Bone lesionFAERS: 8US FAERS
250Cerebral aspergillosisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
251CholecystitisFAERS: 8US FAERS
252Drug effect incompleteFAERS: 8US FAERS
253Ear discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
254EczemaFAERS: 8US FAERS
255Erythema NodosumFAERS: 8US FAERS
256Gastrointestinal toxicityFAERS: 8US FAERS
257HepatomegalyFAERS: 8US FAERS
258Intentional product use issueFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
259Macular degenerationFAERS: 8US FAERS
260MeningitisFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
261Pain of skinFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
262Product physical issueFAERS: 8US FAERS
263Renal painFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Respiratory distressFAERS: 8US FAERS
265Stem cell transplantFAERS: 8
Canada Vigilance: 10
Canada Vigilance
US FAERS
266Synovial CystFAERS: 8US FAERS
267Wound InfectionFAERS: 8
Canada Vigilance: 5
Canada Vigilance
US FAERS
268AbasiaFAERS: 7US FAERS
269AbscessFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
270Activities of daily living impairedFAERS: 7US FAERS
271Atrioventricular BlockFAERS: 7US FAERS
272Blood lactate dehydrogenase increasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
273Brain AbscessFAERS: 7US FAERS
274CardiotoxicityFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
275CheilitisFAERS: 7US FAERS
276DiplopiaFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
277Drug ineffective for unapproved indicationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
278Electrolyte imbalanceFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
279Escherichia infectionFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
280Fluid overloadFAERS: 7US FAERS
281HepatotoxicityFAERS: 7US FAERS
282HypothyroidismFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
283IncontinenceFAERS: 7US FAERS
284LaryngitisFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
285MalnutritionFAERS: 7SIDER
US FAERS
286MenorrhagiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
287Neutrophil count abnormalFAERS: 7US FAERS
288Platelet aggregation abnormalFAERS: 7US FAERS
289Post procedural complicationFAERS: 7US FAERS
290Post procedural infectionFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
291Pulmonary congestionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Renal massFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
293Skin toxicityFAERS: 7US FAERS
294Therapy non-responderFAERS: 7US FAERS
295Tooth LossFAERS: 7US FAERS
296ToothacheFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
297Tumour haemorrhageFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Upper-airway cough syndromeFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
299Vascular ruptureFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
300nervous system disorderFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
301AgeusiaFAERS: 6US FAERS
302Back disorderFAERS: 6US FAERS
303Cardiac FlutterFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
304Central Nervous System InfectionFAERS: 6US FAERS
305Central nervous system lesionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
306ChokingFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
307Completed SuicideFAERS: 6US FAERS
308Coronary Artery DiseaseFAERS: 6US FAERS
309Dermatitis acneiformFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
310DermatitisFAERS: 6SIDER
US FAERS
311Diffuse Large B-Cell LymphomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
312Drug administered to patient of inappropriate ageFAERS: 6US FAERS
313DysarthriaFAERS: 6US FAERS
314Emotional disorderFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
315EncephalitisFAERS: 6US FAERS
316EructationFAERS: 6
Canada Vigilance: 4
Canada Vigilance
US FAERS
317Eye painFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
318Frustration tolerance decreasedFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
319GangreneFAERS: 6US FAERS
320GlaucomaFAERS: 6US FAERS
321Head discomfortFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
322HepatitisFAERS: 6US FAERS
323Hip surgeryFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
324Initial insomniaFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
325Intentional product misuseFAERS: 6US FAERS
326Intestinal PerforationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
327IritisFAERS: 6US FAERS
328Limb injuryFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
329Lip swellingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
330Mantle cell lymphoma recurrentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
331Micrographic skin surgeryFAERS: 6US FAERS
332Musculoskeletal discomfortFAERS: 6SIDER
US FAERS
333NocturiaFAERS: 6US FAERS
334Noninfective gingivitisFAERS: 6US FAERS
335OnychomycosisFAERS: 6US FAERS
336Oral candidiasisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Otitis MediaFAERS: 6US FAERS
338PharyngitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
339PresyncopeFAERS: 6US FAERS
340Respiratory tract congestionFAERS: 6US FAERS
341SunburnFAERS: 6US FAERS
342Unresponsive to stimuliFAERS: 6US FAERS
343Viral upper respiratory tract infectionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
344skin abrasionFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
345Abdominal massFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
346Acute Coronary SyndromeFAERS: 5US FAERS
347AngioedemaFAERS: 5US FAERS
348Aortic AneurysmFAERS: 5US FAERS
349Atypical pneumoniaFAERS: 5US FAERS
350Benign Prostatic HyperplasiaFAERS: 5US FAERS
351BlepharitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
352Blood glucose abnormalFAERS: 5US FAERS
353Blood magnesium decreasedFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
354Blood potassium abnormalFAERS: 5US FAERS
355Blood pressure fluctuationFAERS: 5US FAERS
356BronchiectasisFAERS: 5US FAERS
357CachexiaFAERS: 5US FAERS
358CystFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
359Decreased immune responsivenessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
360Disease complicationFAERS: 5US FAERS
361Drug prescribing errorFAERS: 5US FAERS
362Expired product administeredFAERS: 5US FAERS
363Full blood count decreasedFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
364Gastric ulcerFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
365GastroenteritisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
366Gastrointestinal infectionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
367Hepatitis BFAERS: 5US FAERS
368HydronephrosisFAERS: 5US FAERS
369Hypertensive crisisFAERS: 5US FAERS
370HypokinesiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
371Limb operationFAERS: 5US FAERS
372Lipase increasedFAERS: 5US FAERS
373LymphopeniaFAERS: 5US FAERS
374Medical procedureFAERS: 5US FAERS
375NervousnessFAERS: 5US FAERS
376OnychalgiaFAERS: 5US FAERS
377PallorFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
378Pancreatic carcinomaFAERS: 5US FAERS
379Precancerous skin lesionFAERS: 5US FAERS
380Product quality issueFAERS: 5US FAERS
381Retinal Vein OcclusionFAERS: 5US FAERS
382RhinitisFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
383Skin irritationFAERS: 5US FAERS
384Skin necrosisFAERS: 5US FAERS
385SneezingFAERS: 5US FAERS
386Subcutaneous AbscessFAERS: 5US FAERS
387TachyarrhythmiaFAERS: 5US FAERS
388Thermal burnFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
389ThirstFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
390ThrombocytosisFAERS: 5US FAERS
391TonsillitisFAERS: 5US FAERS
392VasculitisFAERS: 5US FAERS
393Actinic keratosisFAERS: 4US FAERS
394AdenocarcinomaFAERS: 4US FAERS
395AgitationFAERS: 4US FAERS
396AneurysmFAERS: 4US FAERS
397Animal biteFAERS: 4US FAERS
398Ankle FractureFAERS: 4US FAERS
399AphoniaFAERS: 4US FAERS
400Aspergillus test positiveFAERS: 4US FAERS
401AtelectasisFAERS: 4US FAERS
402BedriddenFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
403Blood bilirubin abnormalFAERS: 4US FAERS
404Blood immunoglobulin A decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
405Blood sodium increasedFAERS: 4US FAERS
406Bowel movement irregularityFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
407Cardiac dysfunctionFAERS: 4US FAERS
408Complication associated with deviceFAERS: 4US FAERS
409CryingFAERS: 4US FAERS
410Dental cariesFAERS: 4US FAERS
411DysgraphiaFAERS: 4US FAERS
412EndocarditisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
413Exposure via body fluidFAERS: 4US FAERS
414Eye InfectionFAERS: 4
Canada Vigilance: 6
Canada Vigilance
US FAERS
415Flank PainFAERS: 4US FAERS
416Food PoisoningFAERS: 4US FAERS
417FractureFAERS: 4US FAERS
418Full blood count abnormalFAERS: 4US FAERS
419Gingival RecessionFAERS: 4US FAERS
420Histiocytosis haematophagicFAERS: 4US FAERS
421HydrocephalusFAERS: 4US FAERS
422HyperleukocytosisFAERS: 4US FAERS
423IleusFAERS: 4US FAERS
424Immunoglobulins abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
425IncoherentFAERS: 4US FAERS
426InfarctionFAERS: 4US FAERS
427Irritable Bowel SyndromeFAERS: 4US FAERS
428Joint stiffnessFAERS: 4
Canada Vigilance: 4
Canada Vigilance
US FAERS
429Limb massFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
430Lymphocytic infiltrationFAERS: 4US FAERS
431Mechanical ventilationFAERS: 4US FAERS
432Mental impairmentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
433Middle insomniaFAERS: 4US FAERS
434Mood swingsFAERS: 4US FAERS
435Muscle tightnessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
436MyocarditisFAERS: 4US FAERS
437NecrosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
438Occult blood positiveFAERS: 4US FAERS
439Optic NeuritisFAERS: 4US FAERS
440Oral mucosal erythemaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
441ParanoiaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
442Pleuritic painFAERS: 4US FAERS
443Post procedural swellingFAERS: 4US FAERS
444Product blister packaging issueFAERS: 4US FAERS
445Pulmonary HypertensionFAERS: 4US FAERS
446Respiratory tract infection fungalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
447Restless Legs SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
448RhabdomyolysisFAERS: 4US FAERS
449Rhinovirus infectionFAERS: 4US FAERS
450Right ventricular failureFAERS: 4US FAERS
451RosaceaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
452Spinal column stenosisFAERS: 4US FAERS
453Squamous cell carcinoma of lungFAERS: 4US FAERS
454Sudden Cardiac DeathFAERS: 4US FAERS
455TuberculosisFAERS: 4US FAERS
456Walking aid userFAERS: 4US FAERS
457Abdominal InfectionFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
458Accidental exposure to productFAERS: 3US FAERS
459Acute sinusitisFAERS: 3US FAERS
460AmyloidosisFAERS: 3US FAERS
461Anorectal discomfortFAERS: 3US FAERS
462ApathyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
463Apparent deathFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
464ArteriosclerosisFAERS: 3US FAERS
465BalanoposthitisFAERS: 3US FAERS
466Bladder NeoplasmFAERS: 3US FAERS
467Blood calcium abnormalFAERS: 3US FAERS
468Blood cholesterol increasedFAERS: 3US FAERS
469Blood creatine phosphokinase increasedFAERS: 3US FAERS
470Blood immunoglobulin M abnormalFAERS: 3US FAERS
471Bone abscessFAERS: 3US FAERS
472Bowen's DiseaseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
473Cerebral InfarctionFAERS: 3US FAERS
474Choking sensationFAERS: 3US FAERS
475CholestasisFAERS: 3US FAERS
476ChylothoraxFAERS: 3US FAERS
477Dacryostenosis acquiredFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
478Depressed Level of ConsciousnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
479Drug ToleranceFAERS: 3US FAERS
480Drug administration errorFAERS: 3US FAERS
481EpicondylitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
482Erectile dysfunctionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
483ErysipelasFAERS: 3US FAERS
484Erythema MultiformeFAERS: 3US FAERS
485Exposure via partnerFAERS: 3US FAERS
486Gastric infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
487Gastrointestinal inflammationFAERS: 3US FAERS
488GlossitisFAERS: 3US FAERS
489HemiparesisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
490Hepatic necrosisFAERS: 3US FAERS
491Hepatitis CFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
492HungerFAERS: 3US FAERS
493Hyperviscosity syndromeFAERS: 3US FAERS
494Impaired gastric emptyingFAERS: 3US FAERS
495Infected biteFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
496LeukoencephalopathyFAERS: 3US FAERS
497ListeriosisFAERS: 3US FAERS
498Loss of personal independence in daily activitiesFAERS: 3US FAERS
499LymphadenitisFAERS: 3US FAERS
500MeningiomaFAERS: 3US FAERS
501Metabolic acidosisFAERS: 3US FAERS
502MonoplegiaFAERS: 3US FAERS
503MucormycosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
504Musculoskeletal chest painFAERS: 3US FAERS
505MydriasisFAERS: 3US FAERS
506MyelitisFAERS: 3US FAERS
507MyelofibrosisFAERS: 3US FAERS
508Nail bed infectionFAERS: 3US FAERS
509Nail bed tendernessFAERS: 3US FAERS
510No adverse eventFAERS: 3US FAERS
511Non-cardiac chest painFAERS: 3US FAERS
512Nonspecific reactionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
513ObstructionFAERS: 3US FAERS
514Oropharyngeal spasmFAERS: 3US FAERS
515OsteopeniaFAERS: 3US FAERS
516Paranasal sinus hypersecretionFAERS: 3US FAERS
517Peripheral venous diseaseFAERS: 3US FAERS
518Personality ChangeFAERS: 3US FAERS
519PhotophobiaFAERS: 3US FAERS
520Platelet dysfunctionFAERS: 3US FAERS
521Poor peripheral circulationFAERS: 3US FAERS
522Portal HypertensionFAERS: 3US FAERS
523Post procedural contusionFAERS: 3US FAERS
524Post procedural inflammationFAERS: 3US FAERS
525Procedural complicationFAERS: 3US FAERS
526Product packaging quantity issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
527Pseudomonal sepsisFAERS: 3US FAERS
528Pulmonary necrosisFAERS: 3US FAERS
529Quality of life decreasedFAERS: 3US FAERS
530Respiratory arrestFAERS: 3US FAERS
531RetchingFAERS: 3US FAERS
532Retinal DetachmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
533SclerodermaFAERS: 3US FAERS
534ShockFAERS: 3US FAERS
535Sinus headacheFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
536Sinus operationFAERS: 3US FAERS
537Sinus painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
538Skin IndurationFAERS: 3US FAERS
539Skin PapillomaFAERS: 3US FAERS
540Splenic neoplasm malignancy unspecifiedFAERS: 3US FAERS
541Temperature intoleranceFAERS: 3US FAERS
542TenosynovitisFAERS: 3US FAERS
543Terminal stateFAERS: 3US FAERS
544Therapeutic product ineffectiveFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
545Therapy cessationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
546Thrombotic strokeFAERS: 3US FAERS
547Tongue discomfortFAERS: 3US FAERS
548Tooth InfectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
549Transfusion ReactionFAERS: 3US FAERS
550Trigeminal NeuralgiaFAERS: 3US FAERS
551Urinary tract infection pseudomonalFAERS: 3US FAERS
552VIIth nerve paralysisFAERS: 3US FAERS
553Vaginal DischargeFAERS: 3US FAERS
554VertebroplastyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
555Vitreous floatersFAERS: 3US FAERS
556Vulvovaginal discomfortFAERS: 3US FAERS
557Wound infection staphylococcalFAERS: 3US FAERS
558colonoscopyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
559AgranulocytosisFAERS: 2US FAERS
560Allergy to arthropod biteFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
561Altered state of consciousnessFAERS: 2US FAERS
562Amylase increasedFAERS: 2US FAERS
563Anal UlcerFAERS: 2US FAERS
564Anal fistula infectionFAERS: 2US FAERS
565Anaphylactic shockFAERS: 2US FAERS
566AngerFAERS: 2US FAERS
567Animal scratchFAERS: 2US FAERS
568Antibiotic therapyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
569AnuriaFAERS: 2US FAERS
570ArteritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
571Atrial tachycardiaFAERS: 2US FAERS
572Autoimmune neutropeniaFAERS: 2US FAERS
573Blood albumin abnormalFAERS: 2US FAERS
574Blood albumin decreasedFAERS: 2US FAERS
575Blood carbon monoxide increasedFAERS: 2US FAERS
576Blood creatinine abnormalFAERS: 2US FAERS
577Blood electrolytes abnormalFAERS: 2US FAERS
578Blood glucose fluctuationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
579Blood lactate dehydrogenase decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
580Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
581Blood viscosity abnormalFAERS: 2US FAERS
582Bursitis infective staphylococcalFAERS: 2US FAERS
583BursitisFAERS: 2US FAERS
584Carpal Tunnel SyndromeFAERS: 2US FAERS
585Catheter placementFAERS: 2US FAERS
586Central venous catheter removalFAERS: 2US FAERS
587Cerebral ThrombosisFAERS: 2US FAERS
588Cerebral disorderFAERS: 2US FAERS
589ChemotherapyFAERS: 2US FAERS
590CholangitisFAERS: 2US FAERS
591Cold sweatFAERS: 2US FAERS
592ColectomyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
593Compression fractureFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
594Consciousness fluctuatingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Contrast media allergyFAERS: 2US FAERS
596Critical IllnessFAERS: 2US FAERS
597Deafness NeurosensoryFAERS: 2US FAERS
598Device occlusionFAERS: 2US FAERS
599Device related sepsisFAERS: 2US FAERS
600Diabetes mellitus inadequate controlFAERS: 2US FAERS
601Disease recurrenceFAERS: 2US FAERS
602Disseminated Intravascular CoagulationFAERS: 2US FAERS
603Diverticular perforationFAERS: 2US FAERS
604DiverticulumFAERS: 2US FAERS
605Drug dispensing errorFAERS: 2US FAERS
606Drug withdrawal syndromeFAERS: 2US FAERS
607DyscheziaFAERS: 2US FAERS
608DysenteryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
609DysphemiaFAERS: 2US FAERS
610Ear congestionFAERS: 2US FAERS
611Eating disorder symptomFAERS: 2US FAERS
612Embolic cerebral infarctionFAERS: 2US FAERS
613EmbolismFAERS: 2US FAERS
614Endotracheal intubation complicationFAERS: 2US FAERS
615Enteral NutritionFAERS: 2US FAERS
616EnteritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
617EnterocolitisFAERS: 2US FAERS
618Evans syndromeFAERS: 2US FAERS
619Exfoliative rashFAERS: 2US FAERS
620Eye inflammationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
621Eyelid margin crustingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
622Feeling of body temperature changeFAERS: 2US FAERS
623FolliculitisFAERS: 2US FAERS
624Foreign body sensation in eyesFAERS: 2US FAERS
625Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
626Gastric BypassFAERS: 2US FAERS
627Gastrointestinal PainFAERS: 2SIDER
US FAERS
628Gastrointestinal erosionFAERS: 2US FAERS
629Gastrointestinal motility disorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
630GastrostomyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
631General physical condition abnormalFAERS: 2US FAERS
632Genital HerpesFAERS: 2US FAERS
633Granulocyte count decreasedFAERS: 2US FAERS
634Guillain-Barre SyndromeFAERS: 2US FAERS
635Hallucinations, mixedFAERS: 2US FAERS
636Hepatitis B core antibody positiveFAERS: 2US FAERS
637Hepatitis EFAERS: 2US FAERS
638Human anaplasmosisFAERS: 2US FAERS
639HyperkeratosisFAERS: 2US FAERS
640HyperphagiaFAERS: 2US FAERS
641HyperthyroidismFAERS: 2US FAERS
642HypertransaminasaemiaFAERS: 2US FAERS
643HysterectomyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
644Idiopathic Pulmonary FibrosisFAERS: 2US FAERS
645Incorrect route of drug administrationFAERS: 2US FAERS
646Infected cystFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
647Infectious pleural effusionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
648Infective glossitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
649Infrequent bowel movementsFAERS: 2US FAERS
650Infusion site erythemaFAERS: 2US FAERS
651Infusion site swellingFAERS: 2US FAERS
652Intracranial AneurysmFAERS: 2US FAERS
653IridocyclitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
654Iron deficiencyFAERS: 2US FAERS
655Large intestine perforationFAERS: 2US FAERS
656LipomaFAERS: 2US FAERS
657Lobar PneumoniaFAERS: 2US FAERS
658Low density lipoprotein increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
659Lower respiratory tract infection fungalFAERS: 2US FAERS
660Lung AbscessFAERS: 2US FAERS
661Lung infection pseudomonalFAERS: 2US FAERS
662Lymphocyte count abnormalFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
663Lymphoma transformationFAERS: 2US FAERS
664MalabsorptionFAERS: 2US FAERS
665Mallory-Weiss SyndromeFAERS: 2US FAERS
666Mastoid effusionFAERS: 2US FAERS
667MastoiditisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
668Medication ErrorFAERS: 2US FAERS
669MegacolonFAERS: 2US FAERS
670Meniscus injuryFAERS: 2US FAERS
671Metastases to muscleFAERS: 2US FAERS
672Mouth swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
673Muscle FatigueFAERS: 2US FAERS
674Myocardial necrosis marker increasedFAERS: 2US FAERS
675Nail InfectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
676NeurocryptococcosisFAERS: 2US FAERS
677Neutropenic sepsisFAERS: 2US FAERS
678Neutrophilic dermatosisFAERS: 2US FAERS
679Oral fungal infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
680Oral infectionFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
681Oral mucosal eruptionFAERS: 2US FAERS
682OrchitisFAERS: 2US FAERS
683OsteolysisFAERS: 2US FAERS
684Palatal swellingFAERS: 2US FAERS
685Palliative CareFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
686ParaparesisFAERS: 2US FAERS
687ParaplegiaFAERS: 2US FAERS
688ParesisFAERS: 2US FAERS
689Pathological fractureFAERS: 2US FAERS
690Penile necrosisFAERS: 2US FAERS
691Peptic UlcerFAERS: 2US FAERS
692Performance status decreasedFAERS: 2US FAERS
693PlasmapheresisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
694Platelet TransfusionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
695PleuropericarditisFAERS: 2US FAERS
696Pneumococcal sepsisFAERS: 2US FAERS
697Post procedural cellulitisFAERS: 2US FAERS
698Post procedural persistent drain fluidFAERS: 2US FAERS
699Post procedural strokeFAERS: 2US FAERS
700Posterior reversible encephalopathy syndromeFAERS: 2US FAERS
701Pre-existing condition improvedFAERS: 2US FAERS
702Prescribed overdoseFAERS: 2US FAERS
703Product availability issueFAERS: 2US FAERS
704Product size issueFAERS: 2US FAERS
705Product storage errorFAERS: 2US FAERS
706Product used for unknown indicationFAERS: 2US FAERS
707Protein total decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
708Protein total increasedFAERS: 2US FAERS
709Psychiatric symptomFAERS: 2US FAERS
710Psychogenic seizureFAERS: 2US FAERS
711PyelonephritisFAERS: 2US FAERS
712Rebound effectFAERS: 2US FAERS
713Renal cystFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
714Renal tubular necrosisFAERS: 2US FAERS
715RestlessnessFAERS: 2US FAERS
716Retinal Artery OcclusionFAERS: 2US FAERS
717Rheumatoid ArthritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
718SarcoidosisFAERS: 2US FAERS
719SarcomaFAERS: 2US FAERS
720Scedosporium infectionFAERS: 2US FAERS
721Scrotal InfectionFAERS: 2US FAERS
722Secretion dischargeFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
723Sinus TachycardiaFAERS: 2US FAERS
724Sinus bradycardiaFAERS: 2US FAERS
725Skin graft contractureFAERS: 2US FAERS
726SluggishnessFAERS: 2US FAERS
727SplenectomyFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
728StarvationFAERS: 2US FAERS
729Suicide attemptFAERS: 2US FAERS
730Superinfection bacterialFAERS: 2US FAERS
731SuperinfectionFAERS: 2US FAERS
732Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
733TensionFAERS: 2US FAERS
734Therapeutic procedureFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
735Therapy changeFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
736Thyroid hormones decreasedFAERS: 2US FAERS
737Toe operationFAERS: 2US FAERS
738Tongue blisteringFAERS: 2US FAERS
739Tracheostomy malfunctionFAERS: 2US FAERS
740TrichorrhexisFAERS: 2US FAERS
741Troponin increasedFAERS: 2US FAERS
742Tympanic Membrane PerforationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
743Umbilical herniaFAERS: 2US FAERS
744Urinary tract infection fungalFAERS: 2US FAERS
745Urinary tract stoma complicationFAERS: 2US FAERS
746Urine cytology abnormalFAERS: 2US FAERS
747Urine viscosity increasedFAERS: 2US FAERS
748Vascular occlusionFAERS: 2US FAERS
749Vitreous DetachmentFAERS: 2US FAERS
750VulvitisFAERS: 2US FAERS
751Vulvovaginal painFAERS: 2US FAERS
752West Nile viral infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
753Wound abscessFAERS: 2US FAERS
754treatment failureFAERS: 2US FAERS
755Abdominal AbscessFAERS: 1US FAERS
756Abdominal cavity drainageFAERS: 1US FAERS
757Abdominal sepsisFAERS: 1US FAERS
758Abdominal tendernessFAERS: 1US FAERS
759Abscess fungalFAERS: 1US FAERS
760Acanthamoeba InfectionFAERS: 1US FAERS
761Accidental exposure to product by childFAERS: 1US FAERS
762Acute Lung InjuryFAERS: 1US FAERS
763Alcohol IntoleranceFAERS: 1US FAERS
764AlveolitisFAERS: 1US FAERS
765Ammonia increasedFAERS: 1US FAERS
766AmputationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
767Amyotrophic Lateral SclerosisFAERS: 1US FAERS
768Anal FissureFAERS: 1US FAERS
769Anal FistulaFAERS: 1US FAERS
770Anal abscessFAERS: 1US FAERS
771Angle Closure GlaucomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
772Anorectal cellulitisFAERS: 1US FAERS
773AnosmiaFAERS: 1US FAERS
774AphagiaFAERS: 1US FAERS
775Application site painFAERS: 1US FAERS
776Artificial crown procedureFAERS: 1US FAERS
777AspergillomaFAERS: 1US FAERS
778AsphyxiaFAERS: 1US FAERS
779AtaxiaFAERS: 1US FAERS
780Band neutrophil percentage increasedFAERS: 1US FAERS
781Benign neoplasm of thyroid glandFAERS: 1US FAERS
782Biopsy bone marrow abnormalFAERS: 1US FAERS
783Biopsy skin abnormalFAERS: 1US FAERS
784Bipolar I disorderFAERS: 1US FAERS
785Bladder cancer recurrentFAERS: 1US FAERS
786Bladder painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
787Bladder prolapseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
788Blister ruptureFAERS: 1US FAERS
789Blood cholesterol abnormalFAERS: 1US FAERS
790Blood creatine abnormalFAERS: 1US FAERS
791Blood immunoglobulin G abnormalFAERS: 1US FAERS
792Blood iron abnormalFAERS: 1US FAERS
793Blood iron increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
794Blood parathyroid hormone abnormalFAERS: 1US FAERS
795Blood sodium abnormalFAERS: 1US FAERS
796Blood urea increasedFAERS: 1US FAERS
797Blood viscosity decreasedFAERS: 1US FAERS
798Body TemperatureFAERS: 1US FAERS
799Bone density decreasedFAERS: 1US FAERS
800Bone marrow infiltrationFAERS: 1US FAERS
801Bone marrow necrosisFAERS: 1US FAERS
802Bone marrow toxicityFAERS: 1US FAERS
803BradyphreniaFAERS: 1US FAERS
804Brain ContusionFAERS: 1US FAERS
805Brain scan abnormalFAERS: 1US FAERS
806Breast cancer stage IIFAERS: 1US FAERS
807Breast tendernessFAERS: 1US FAERS
808BronchiolitisFAERS: 1US FAERS
809BronchospasmFAERS: 1US FAERS
810C-reactive protein decreasedFAERS: 1US FAERS
811CD4/CD8 ratio increasedFAERS: 1US FAERS
812Campylobacter sepsisFAERS: 1US FAERS
813Candida pneumoniaFAERS: 1US FAERS
814Capillary FragilityFAERS: 1US FAERS
815Carbon dioxide increasedFAERS: 1US FAERS
816Cardiac DeathFAERS: 1US FAERS
817Cardiac ablationFAERS: 1US FAERS
818Cardiac valve vegetationFAERS: 1US FAERS
819Cardiac ventricular thrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
820CarditisFAERS: 1US FAERS
821Carotid Artery ThrombosisFAERS: 1US FAERS
822Carotid artery occlusionFAERS: 1US FAERS
823Cataract operationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
824Catheter site cellulitisFAERS: 1US FAERS
825Catheter site painFAERS: 1US FAERS
826Catheter site swellingFAERS: 1US FAERS
827Catheter site ulcerFAERS: 1US FAERS
828Cauda Equina SyndromeFAERS: 1US FAERS
829Cell DeathFAERS: 1US FAERS
830Central nervous system massFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
831Cerebral microhaemorrhageFAERS: 1US FAERS
832Cervical dysplasiaFAERS: 1US FAERS
833Cholecystitis infectiveFAERS: 1US FAERS
834ChorioretinitisFAERS: 1US FAERS
835Chronic Fatigue SyndromeFAERS: 1US FAERS
836Chronic graft versus host disease in liverFAERS: 1US FAERS
837Chronic sinusitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
838Coagulation factor VIII level decreasedFAERS: 1US FAERS
839Coagulation time shortenedFAERS: 1US FAERS
840Coating in mouthFAERS: 1US FAERS
841Complication of device removalFAERS: 1US FAERS
842Corneal exfoliationFAERS: 1US FAERS
843Coxsackie virus test positiveFAERS: 1US FAERS
844Creatinine renal clearance decreasedFAERS: 1US FAERS
845Cutaneous lymphomaFAERS: 1US FAERS
846CyanosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
847CystoscopyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
848Cytomegalovirus test positiveFAERS: 1US FAERS
849Cytomegalovirus testFAERS: 1US FAERS
850Delayed sleep phaseFAERS: 1US FAERS
851Delirium febrileFAERS: 1US FAERS
852Device dislocationFAERS: 1US FAERS
853Device malfunctionFAERS: 1US FAERS
854Device related infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
855Dialysis device insertionFAERS: 1US FAERS
856Diastolic dysfunctionFAERS: 1US FAERS
857Drug DependenceFAERS: 1US FAERS
858Drug effect delayedFAERS: 1US FAERS
859Drug screen positiveFAERS: 1US FAERS
860Drug withdrawal headacheFAERS: 1US FAERS
861DysplasiaFAERS: 1US FAERS
862Dystonic tremorFAERS: 1US FAERS
863Ejection fraction abnormalFAERS: 1US FAERS
864Electrocardiogram abnormalFAERS: 1US FAERS
865EmpyemaFAERS: 1US FAERS
866Endometrial adenocarcinomaFAERS: 1US FAERS
867Endometrial thickeningFAERS: 1US FAERS
868EndophthalmitisFAERS: 1US FAERS
869EnterobiasisFAERS: 1US FAERS
870Enterococcal infectionFAERS: 1US FAERS
871Enzyme level increasedFAERS: 1US FAERS
872EosinophiliaFAERS: 1US FAERS
873Eosinophilic myocarditisFAERS: 1US FAERS
874Epidermal necrosisFAERS: 1US FAERS
875EpidermolysisFAERS: 1US FAERS
876Epigastric discomfortFAERS: 1US FAERS
877Erythema InduratumFAERS: 1US FAERS
878Eye excisionFAERS: 1US FAERS
879Eyelid irritationFAERS: 1US FAERS
880Facial PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
881Facial ParesisFAERS: 1US FAERS
882FasciitisFAERS: 1US FAERS
883Fat necrosisFAERS: 1US FAERS
884Feeling jitteryFAERS: 1US FAERS
885Fixed eruptionFAERS: 1US FAERS
886Fluid imbalanceFAERS: 1US FAERS
887Food aversionFAERS: 1US FAERS
888Food cravingFAERS: 1US FAERS
889Foreign body in respiratory tractFAERS: 1US FAERS
890GastrectomyFAERS: 1US FAERS
891Gastric pH decreasedFAERS: 1US FAERS
892Gastroduodenitis haemorrhagicFAERS: 1US FAERS
893Gastrointestinal adenocarcinomaFAERS: 1US FAERS
894Gastrointestinal carcinomaFAERS: 1US FAERS
895Gastrointestinal mucosal disorderFAERS: 1US FAERS
896Gastrointestinal perforationFAERS: 1US FAERS
897Gastrointestinal ulcerFAERS: 1US FAERS
898Genital erythemaFAERS: 1US FAERS
899Genital painFAERS: 1US FAERS
900Genital rashFAERS: 1US FAERS
901Gingival AtrophyFAERS: 1US FAERS
902Glioblastoma MultiformeFAERS: 1US FAERS
903GlomerulonephritisFAERS: 1US FAERS
904GlossectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
905Graft versus host disease in liverFAERS: 1US FAERS
906Granulomatous dermatitisFAERS: 1US FAERS
907Granulomatous liver diseaseFAERS: 1US FAERS
908Grip strength decreasedFAERS: 1US FAERS
909Hair injuryFAERS: 1US FAERS
910Haptoglobin DecreasedFAERS: 1US FAERS
911Head and neck cancer metastaticFAERS: 1US FAERS
912Heart alternationFAERS: 1US FAERS
913HemiplegiaFAERS: 1US FAERS
914Hemiplegic migraineFAERS: 1US FAERS
915Hepatic cancer metastaticFAERS: 1US FAERS
916Hepatic congestionFAERS: 1US FAERS
917Hepatitis AFAERS: 1US FAERS
918Herpes zoster cutaneous disseminatedFAERS: 1US FAERS
919Histiocytic sarcomaFAERS: 1US FAERS
920HordeolumFAERS: 1US FAERS
921Human chorionic gonadotropin increasedFAERS: 1US FAERS
922HyperchlorhydriaFAERS: 1US FAERS
923HypermetabolismFAERS: 1US FAERS
924HyperpyrexiaFAERS: 1US FAERS
925Hypertensive heart diseaseFAERS: 1US FAERS
926HypertrichosisFAERS: 1US FAERS
927HyperventilationFAERS: 1US FAERS
928Hyporesponsive to stimuliFAERS: 1US FAERS
929Hypothalamo-pituitary disorderFAERS: 1US FAERS
930ImmobileFAERS: 1US FAERS
931Immune Reconstitution Inflammatory SyndromeFAERS: 1US FAERS
932Immunoglobulin TherapyFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
933Immunology test abnormalFAERS: 1US FAERS
934Impaired self-careFAERS: 1US FAERS
935Impaired work abilityFAERS: 1US FAERS
936ImpetigoFAERS: 1US FAERS
937Incarcerated herniaFAERS: 1US FAERS
938Incorrect dose administered by deviceFAERS: 1US FAERS
939Incorrect product formulation administeredFAERS: 1US FAERS
940Incorrect route of product administrationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
941Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
942Infected fistulaFAERS: 1US FAERS
943Infectious colitisFAERS: 1US FAERS
944Inflammatory painFAERS: 1US FAERS
945Infusion site infectionFAERS: 1US FAERS
946Infusion site reactionFAERS: 1US FAERS
947Inguinal massFAERS: 1US FAERS
948Injection site erythemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
949Injection site infectionFAERS: 1US FAERS
950Intellectual DisabilityFAERS: 1US FAERS
951Intervertebral disc compressionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
952Intervertebral disc disorderFAERS: 1US FAERS
953Intracranial massFAERS: 1US FAERS
954JC polyomavirus test positiveFAERS: 1US FAERS
955JC virus infectionFAERS: 1US FAERS
956JC virus test positiveFAERS: 1US FAERS
957Joint abscessFAERS: 1US FAERS
958Joint warmthFAERS: 1US FAERS
959KetoacidosisFAERS: 1US FAERS
960Lacrimation decreasedFAERS: 1US FAERS
961Laser TherapyFAERS: 1US FAERS
962Left Ventricular HypertrophyFAERS: 1US FAERS
963LithotripsyFAERS: 1US FAERS
964Livedo ReticularisFAERS: 1US FAERS
965Liver function test decreasedFAERS: 1US FAERS
966Localised intraabdominal fluid collectionFAERS: 1US FAERS
967Loose toothFAERS: 1US FAERS
968Lower respiratory tract inflammationFAERS: 1US FAERS
969Lung consolidationFAERS: 1US FAERS
970Lymph node palpableFAERS: 1US FAERS
971Lymphatic duct injuryFAERS: 1US FAERS
972Lymphocyte percentage abnormalFAERS: 1US FAERS
973Macular fibrosisFAERS: 1US FAERS
974MaculeFAERS: 1US FAERS
975Malignant anorectal neoplasmFAERS: 1US FAERS
976Manufacturing materials issueFAERS: 1US FAERS
977MastectomyFAERS: 1US FAERS
978MastitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
979Maternal exposure during pregnancyFAERS: 1US FAERS
980MeaslesFAERS: 1US FAERS
981Medical device site infectionFAERS: 1US FAERS
982Meningeal disorderFAERS: 1US FAERS
983Metastases to peripheral vascular systemFAERS: 1US FAERS
984Metastatic NeoplasmFAERS: 1US FAERS
985Microvascular coronary artery diseaseFAERS: 1US FAERS
986Mitral Valve StenosisFAERS: 1US FAERS
987MoaningFAERS: 1US FAERS
988Monoclonal immunoglobulin presentFAERS: 1US FAERS
989Monocyte count decreasedFAERS: 1US FAERS
990Monocyte count increasedFAERS: 1US FAERS
991MonocytosisFAERS: 1US FAERS
992Multi-organ disorderFAERS: 1US FAERS
993MultimorbidityFAERS: 1US FAERS
994Multiple allergiesFAERS: 1US FAERS
995Muscle abscessFAERS: 1US FAERS
996Myasthenia GravisFAERS: 1US FAERS
997Mycobacterium test positiveFAERS: 1US FAERS
998Mycobacterium tuberculosis complex test positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
999Myeloblast presentFAERS: 1US FAERS
1000MyositisFAERS: 1US FAERS
1001Nail cuticle fissureFAERS: 1US FAERS
1002Nasal discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1003Nasal herpesFAERS: 1US FAERS
1004NephrectomyFAERS: 1US FAERS
1005NephritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1006Nephrotic SyndromeFAERS: 1US FAERS
1007Nerve DegenerationFAERS: 1US FAERS
1008Nerve Root CompressionFAERS: 1US FAERS
1009Nerve injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1010Neurological decompensationFAERS: 1US FAERS
1011Nodular rashFAERS: 1US FAERS
1012Occupational exposure to productFAERS: 1US FAERS
1013Ocular discomfortFAERS: 1US FAERS
1014Ocular icterusFAERS: 1US FAERS
1015Ocular vascular disorderFAERS: 1US FAERS
1016OnycholysisFAERS: 1US FAERS
1017Oral mucosal exfoliationFAERS: 1US FAERS
1018Oropharyngeal blisteringFAERS: 1US FAERS
1019Oropharyngeal candidiasisFAERS: 1US FAERS
1020Osteomyelitis fungalFAERS: 1US FAERS
1021Otitis ExternaFAERS: 1US FAERS
1022Oxygen saturation abnormalFAERS: 1US FAERS
1023PanophthalmitisFAERS: 1US FAERS
1024ParacentesisFAERS: 1US FAERS
1025Paraneoplastic pemphigusFAERS: 1US FAERS
1026Parasitic gastroenteritisFAERS: 1US FAERS
1027Parkinsonian crisisFAERS: 1US FAERS
1028ParotitisFAERS: 1US FAERS
1029Pathogen resistanceFAERS: 1US FAERS
1030Pelvic massFAERS: 1US FAERS
1031PemphigusFAERS: 1US FAERS
1032Penile InfectionFAERS: 1US FAERS
1033Peptic Ulcer PerforationFAERS: 1US FAERS
1034PeriarthritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1035Perineal infectionFAERS: 1US FAERS
1036Peripheral arterial occlusive diseaseFAERS: 1US FAERS
1037Peripheral artery occlusionFAERS: 1US FAERS
1038Peripheral embolismFAERS: 1US FAERS
1039Peritoneal perforationFAERS: 1US FAERS
1040PhlebitisFAERS: 1US FAERS
1041Plasmablastic lymphomaFAERS: 1US FAERS
1042Pleural InfectionFAERS: 1US FAERS
1043Pleural infection bacterialFAERS: 1US FAERS
1044Pneumatosis intestinalisFAERS: 1US FAERS
1045PneumocephalusFAERS: 1US FAERS
1046Polyarteritis NodosaFAERS: 1US FAERS
1047PolyarthritisFAERS: 1US FAERS
1048PolydipsiaFAERS: 1US FAERS
1049Polyglandular disorderFAERS: 1US FAERS
1050Polymyalgia RheumaticaFAERS: 1US FAERS
1051Polyomavirus test positiveFAERS: 1US FAERS
1052PolyuriaFAERS: 1US FAERS
1053Poor quality drug administeredFAERS: 1US FAERS
1054Post procedural dischargeFAERS: 1US FAERS
1055Post-traumatic painFAERS: 1US FAERS
1056Postoperative adhesionFAERS: 1US FAERS
1057Postoperative thrombosisFAERS: 1US FAERS
1058Precancerous cells presentFAERS: 1US FAERS
1059Precancerous lesion excisionFAERS: 1US FAERS
1060PriapismFAERS: 1US FAERS
1061Primary MyelofibrosisFAERS: 1US FAERS
1062Procedural nauseaFAERS: 1US FAERS
1063Product administered to patient of inappropriate ageFAERS: 1US FAERS
1064Product formulation issueFAERS: 1US FAERS
1065Product label confusionFAERS: 1US FAERS
1066Product leakageFAERS: 1US FAERS
1067Product packaging confusionFAERS: 1US FAERS
1068Product packaging issueFAERS: 1US FAERS
1069ProstatectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1070Prostatic specific antigen decreasedFAERS: 1US FAERS
1071Protein DeficiencyFAERS: 1US FAERS
1072Protein total abnormalFAERS: 1US FAERS
1073ProteinuriaFAERS: 1US FAERS
1074PrurigoFAERS: 1US FAERS
1075PseudocystFAERS: 1US FAERS
1076PseudohyperkalaemiaFAERS: 1US FAERS
1077PseudolymphomaFAERS: 1US FAERS
1078Psychiatric decompensationFAERS: 1US FAERS
1079Pulmonary sepsisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1080Pulmonary toxicityFAERS: 1US FAERS
1081Pulmonary vasculitisFAERS: 1US FAERS
1082RalesFAERS: 1US FAERS
1083Rectal ProlapseFAERS: 1US FAERS
1084Rectal fissureFAERS: 1US FAERS
1085Rectal tenesmusFAERS: 1US FAERS
1086Red blood cell elliptocytes presentFAERS: 1US FAERS
1087Red blood cell morphology abnormalFAERS: 1US FAERS
1088Refractory cancerFAERS: 1US FAERS
1089Renal Cell CarcinomaFAERS: 1US FAERS
1090Renal ColicFAERS: 1US FAERS
1091Renal vascular thrombosisFAERS: 1US FAERS
1092Respiratory DepressionFAERS: 1US FAERS
1093Respiratory fatigueFAERS: 1US FAERS
1094Respiratory muscle weaknessFAERS: 1US FAERS
1095Respiratory tract infection viralFAERS: 1US FAERS
1096Retinal artery embolismFAERS: 1US FAERS
1097Retinal scarFAERS: 1US FAERS
1098Retinal vascular occlusionFAERS: 1US FAERS
1099Retroperitoneal massFAERS: 1US FAERS
1100RhonchiFAERS: 1US FAERS
1101Rotator cuff syndromeFAERS: 1US FAERS
1102Sarcoma of skinFAERS: 1US FAERS
1103Sciatic Nerve PalsyFAERS: 1US FAERS
1104ScleromalaciaFAERS: 1US FAERS
1105Selective eating disorderFAERS: 1US FAERS
1106Semen viscosity decreasedFAERS: 1US FAERS
1107Sensation of blood flowFAERS: 1US FAERS
1108SeromaFAERS: 1US FAERS
1109Seronegative arthritisFAERS: 1US FAERS
1110Sinonasal obstructionFAERS: 1US FAERS
1111Sinus ArrhythmiaFAERS: 1US FAERS
1112Skin WrinklingFAERS: 1US FAERS
1113Skin hypertrophyFAERS: 1US FAERS
1114Skin neoplasm excisionFAERS: 1US FAERS
1115Skin texture abnormalFAERS: 1US FAERS
1116Skin tightnessFAERS: 1US FAERS
1117Sleep TalkingFAERS: 1US FAERS
1118Slow speechFAERS: 1US FAERS
1119Soft Tissue InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1120Somatic dysfunctionFAERS: 1US FAERS
1121Spermatic cord funiculitisFAERS: 1US FAERS
1122Splenic necrosisFAERS: 1US FAERS
1123Sputum culture positiveFAERS: 1US FAERS
1124Staphylococcal Scalded Skin SyndromeFAERS: 1US FAERS
1125Staphylococcus test positiveFAERS: 1US FAERS
1126Stasis dermatitisFAERS: 1US FAERS
1127Status EpilepticusFAERS: 1US FAERS
1128StenosisFAERS: 1US FAERS
1129Streptococcal abscessFAERS: 1US FAERS
1130Suspected counterfeit productFAERS: 1US FAERS
1131Swelling of eyelidFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1132SynovitisFAERS: 1US FAERS
1133Systemic SclerodermaFAERS: 1US FAERS
1134Systemic mycosisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1135T-Cell LymphomaFAERS: 1US FAERS
1136TachyphreniaFAERS: 1US FAERS
1137Temporal ArteritisFAERS: 1US FAERS
1138Tension HeadacheFAERS: 1US FAERS
1139Therapeutic response changedFAERS: 1US FAERS
1140Therapy partial responderFAERS: 1US FAERS
1141Throat cancerFAERS: 1US FAERS
1142Thrombocytopenic purpuraFAERS: 1US FAERS
1143ThrombophlebitisFAERS: 1US FAERS
1144Tinea crurisFAERS: 1US FAERS
1145Tongue eruptionFAERS: 1US FAERS
1146Tongue erythemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1147Tooth ErosionFAERS: 1US FAERS
1148Tooth repairFAERS: 1US FAERS
1149ToxoplasmosisFAERS: 1US FAERS
1150Transfusion related complicationFAERS: 1US FAERS
1151TransplantFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1152Transplantation complicationFAERS: 1US FAERS
1153UreterolithiasisFAERS: 1US FAERS
1154Urinary bladder polypFAERS: 1US FAERS
1155Urinary strainingFAERS: 1US FAERS
1156Urinary tract adhesionsFAERS: 1US FAERS
1157Urine flow decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1158Uterovaginal prolapseFAERS: 1US FAERS
1159Vascular compressionFAERS: 1US FAERS
1160Vascular painFAERS: 1US FAERS
1161Vein collapseFAERS: 1US FAERS
1162Venous thrombosis limbFAERS: 1US FAERS
1163Ventricular DysfunctionFAERS: 1US FAERS
1164Vertebral lesionFAERS: 1US FAERS
1165Viral pericarditisFAERS: 1US FAERS
1166Vulvovaginal burning sensationFAERS: 1US FAERS
1167Vulvovaginal human papilloma virus infectionFAERS: 1US FAERS
1168Vulvovaginal mycotic infectionFAERS: 1US FAERS
1169Vulvovaginal pruritusFAERS: 1US FAERS
1170Vulvovaginal rashFAERS: 1US FAERS
1171ZygomycosisFAERS: 1US FAERS
1172effusionFAERS: 1US FAERS
1173Abdominal rigidityCanada Vigilance: 1Canada Vigilance
1174Air EmbolismCanada Vigilance: 1Canada Vigilance
1175Blood creatinine decreasedCanada Vigilance: 1Canada Vigilance
1176Blood parathyroid hormone increasedCanada Vigilance: 1Canada Vigilance
1177Campylobacter infectionCanada Vigilance: 1Canada Vigilance
1178Cardiac HypertrophyCanada Vigilance: 1Canada Vigilance
1179Cardiac infectionCanada Vigilance: 1Canada Vigilance
1180CoccidioidomycosisCanada Vigilance: 1Canada Vigilance
1181DermatomyositisCanada Vigilance: 1Canada Vigilance
1182Diabetic foot infectionCanada Vigilance: 1Canada Vigilance
1183Emotional distressCanada Vigilance: 1Canada Vigilance
1184Endodontic procedureCanada Vigilance: 1Canada Vigilance
1185Febrile infectionCanada Vigilance: 1Canada Vigilance
1186Gene MutationCanada Vigilance: 1Canada Vigilance
1187Gingival blisterCanada Vigilance: 1Canada Vigilance
1188Hepatic InfectionCanada Vigilance: 1Canada Vigilance
1189Hepatic cyst infectionCanada Vigilance: 1Canada Vigilance
1190HyperacusisCanada Vigilance: 1Canada Vigilance
1191HypohidrosisCanada Vigilance: 1Canada Vigilance
1192InfestationSIDER
1193Intestinal Pseudo-ObstructionCanada Vigilance: 1Canada Vigilance
1194Labile blood pressureCanada Vigilance: 1Canada Vigilance
1195Lip and/or oral cavity cancerCanada Vigilance: 1Canada Vigilance
1196Lower respiratory tract infection bacterialCanada Vigilance: 1Canada Vigilance
1197Lymphoproliferative Disorders23617325CTD
1198Mantle cell lymphoma refractoryCanada Vigilance: 1Canada Vigilance
1199Medical induction of comaCanada Vigilance: 1Canada Vigilance
1200Metastases to stomachCanada Vigilance: 1Canada Vigilance
1201Pelvic PainCanada Vigilance: 1Canada Vigilance
1202Pharyngeal swellingCanada Vigilance: 2Canada Vigilance
1203Plantar erythemaCanada Vigilance: 1Canada Vigilance
1204Post procedural constipationCanada Vigilance: 1Canada Vigilance
1205Post procedural pneumoniaCanada Vigilance: 1Canada Vigilance
1206Product administration errorCanada Vigilance: 2Canada Vigilance
1207Product prescribing errorCanada Vigilance: 1Canada Vigilance
1208RegurgitationCanada Vigilance: 1Canada Vigilance
1209Salivary gland painCanada Vigilance: 1Canada Vigilance
1210Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
1211Thoracic cavity drainageCanada Vigilance: 1Canada Vigilance
1212Thyroid NeoplasmCanada Vigilance: 1Canada Vigilance
1213Urine output increasedCanada Vigilance: 1Canada Vigilance
1214Wound ComplicationCanada Vigilance: 1Canada Vigilance
1215prostatitisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.